PROGESTERONE THERAPY IN PREECLAMPTIC TOXEMIA
PROGESTERONE THERAPY IN PREECLAMPTIC TOXEMIA
复制标题
DOI：
10.3109/00016347509157760
复制
发表时间：
1975-01-01
影响因子：
4.3
通讯作者：
KHALIFA, AS
中科院分区：
文献类型：
--
作者：
SAMMOUR, MB;ELKABARITY, H;KHALIFA, AS
Progesterone was the principal therapeutic agent used in 40 cases of pre-eclamptic toxemia. It was also given to 10 normal pregnant women who served as a control group. A significant fall in both the systolic and diastolic blood pressures was observed in 80% of the toxemic patients. In all cases there was a marked increase in the 24-h urinary output with an apparent loss of weight. Serum uric acid showed a significant drop and the urea clearance values also improved. The serum Na showed an apparent decline while the serum K did not show any marked variation. The serum uric acid, urea clearance, blood urea, serum Na and serum K remained unchanged in the control group.
